UK markets open in 5 hours 8 minutes

CytomX Therapeutics, Inc. (6C1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.7840-0.8480 (-32.22%)
At close: 04:10PM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts8888
Avg. Estimate-0.31-0.23-1.15-1.54
Low estimate-0.43-0.36-1.56-2.11
High estimate-0.160.23-0.62-0.99
Year ago EPS-0.32-0.32-0.71-1.15
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts8888
Avg. Estimate18.08M24.93M75.19M72.22M
Low estimate16M16M64MN/A
High estimate21.51M70.8M119.1M116.05M
Year ago sales17.79M16.37M100.36M75.19M
Sales growth (year/est)1.60%52.30%-25.10%-3.90%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.48-0.5-0.35-0.32
Actual EPS-0.32-0.32-0.26-0.3
Difference0.160.180.090.02
Surprise %33.30%36.00%25.70%6.30%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.31-0.23-1.15-1.54
7 days ago-0.31-0.23-1.15-1.49
30 days ago-0.34-0.31-1.24-1.57
60 days ago-0.37-0.33-1.31-1.66
90 days ago-0.37-0.33-1.32-1.67
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimates6C1.FIndustrySector(s)S&P 500
Current qtr.3.10%N/AN/AN/A
Next qtr.28.10%N/AN/AN/A
Current year-62.00%N/AN/AN/A
Next year-33.90%N/AN/AN/A
Next 5 years (per annum)-0.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A